Buy 3 Momentum Anomaly Stocks as Markets Rise Despite Tariff ThreatsZacks Investment Research • 04/02/25
Fast Company Recognizes GeneDx as One of the World's Most Innovative CompaniesBusiness Wire • 03/18/25
GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual MeetingBusiness Wire • 03/13/25
GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical AnalysisBusiness Wire • 03/13/25
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New IndicationBusiness Wire • 03/04/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp - WGSPRNewsWire • 03/03/25
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Shareholders to ConnectAccesswire • 02/25/25
Landmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current ProtocolsBusiness Wire • 02/24/25
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Reach OutAccesswire • 02/24/25
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Shareholders to Learn More About the InvestigationAccesswire • 02/23/25
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the InvestigationAccesswire • 02/21/25
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the InvestigationAccesswire • 02/20/25
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to ConnectAccesswire • 02/19/25
Reviewing GeneDx Holdings: Exome Testing And EPIC Aura Integration Make It A GARP 'Buy'Seeking Alpha • 02/19/25
Top Biotech GeneDx Catapults 42% After Obliterating Earnings ForecastsInvestors Business Daily • 02/18/25
Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Stockholders to Inquire about Securities InvestigationAccesswire • 02/18/25
GeneDx Holdings Corp. (WGS) Q4 Earnings and Revenues Surpass EstimatesZacks Investment Research • 02/18/25
GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025Business Wire • 02/18/25
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Investors to Learn More About the InvestigationAccesswire • 02/17/25